- Home
- SLGL vs INO Comparison
SLGL vs INO Comparison
Compare SLGL & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- INO
- Stock Information
- Founded
- SLGL 1997
- INO 1979
- Country
- SLGL Israel
- INO United States
- Employees
- SLGL N/A
- INO N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- SLGL Health Care
- INO Health Care
- Exchange
- SLGL Nasdaq
- INO Nasdaq
- Market Cap
- SLGL 69.1M
- INO 69.3M
- IPO Year
- SLGL 2018
- INO 1998
- Fundamental
- Price
- SLGL $26.57
- INO $2.31
- Analyst Decision
- SLGL
- INO Buy
- Analyst Count
- SLGL 0
- INO 5
- Target Price
- SLGL N/A
- INO $8.80
- AVG Volume (30 Days)
- SLGL 32.9K
- INO 2.1M
- Earning Date
- SLGL 11-14-2025
- INO 11-13-2025
- Dividend Yield
- SLGL N/A
- INO N/A
- EPS Growth
- SLGL N/A
- INO N/A
- EPS
- SLGL N/A
- INO N/A
- Revenue
- SLGL $23,931,000.00
- INO $182,337.00
- Revenue This Year
- SLGL N/A
- INO N/A
- Revenue Next Year
- SLGL $31.17
- INO $15,960.33
- P/E Ratio
- SLGL N/A
- INO N/A
- Revenue Growth
- SLGL 264.86
- INO N/A
- 52 Week Low
- SLGL $4.01
- INO $1.30
- 52 Week High
- SLGL $30.00
- INO $7.00
- Technical
- Relative Strength Index (RSI)
- SLGL 65.38
- INO 52.27
- Support Level
- SLGL $23.15
- INO $2.16
- Resistance Level
- SLGL $24.85
- INO $2.98
- Average True Range (ATR)
- SLGL 2.32
- INO 0.20
- MACD
- SLGL -0.41
- INO -0.07
- Stochastic Oscillator
- SLGL 61.43
- INO 18.29
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.